Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers

Sarah T. Diepstraten, Yin Yuan, John E. La Marca, Savannah Young, Catherine Chang, Lauren Whelan, Aisling M. Ross, Karla C. Fischer, Giovanna Pomilio, Rhiannon Morris, Angela Georgiou, Veronique Litalien, Fiona C. Brown, Andrew W. Roberts, Andreas Strasser, Andrew H. Wei, Gemma L. Kelly

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science